Christopher Brett Primiano - 28 Oct 2021 Form 3 Insider Report for Aura Biosciences, Inc. (AURA)

Role
Chief Business Officer
Signature
/s/ Julie Feder
Issuer symbol
AURA
Transactions as of
28 Oct 2021
Net transactions value
$0
Form type
3
Filing time
28 Oct 2021, 20:18:18 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AURA Stock Option (Right to Buy) 28 Oct 2021 Common Stock 124,087 $9.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest as follows: 25% of the shares vest on the first anniversary of September 20, 2021 with the remainder vesting in 36 substantially equal monthly instalments thereafter.